CELLDEX THERAPEUTICS INC (CLDX) Stock Cash Flow
NASDAQ:CLDX - Nasdaq - US15117B2025 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -178.85M | -157.86M | -141.43M | -112.33M | -70.51M | |||
| Depreciation Amortization | 3.27M | 3.18M | 3.01M | 2.90M | 3.07M | |||
| Change In Working Capital | -17.59M | -21.60M | 13.46M | -3.90M | -1.05M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 21.66M | 18.51M | 17.67M | 9.60M | 7.59M | |||
| OPERATING CASH FLOW | -171.51M | -157.78M | -107.29M | -103.73M | -60.91M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.84M | -1.92M | -1.82M | -1.83M | -1.25M | |||
| Other Investing Activity | 69.87M | -288.21M | -103.96M | 91.77M | -214.91M | |||
| INVESTING CASH FLOW | 68.03M | -290.13M | -105.78M | 89.94M | -216.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | N/A | 432.30M | 216.22M | 0.00 | 269.89M | |||
| Other Financing Activity | 5.54M | 9.15M | 2.24M | 4.08M | 2.48M | |||
| FINANCING CASH FLOW | 5.54M | 441.45M | 218.46M | 4.08M | 272.37M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -97.94M | -6.46M | 5.38M | -9.71M | -4.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -171.51M | -157.78M | -107.29M | -103.73M | -60.91M | |||
| Capital Expenditure | -1.84M | -1.92M | -1.82M | -1.83M | -1.25M | |||
| FREE CASH FLOW | -173.35M | -159.70M | -109.11M | -105.56M | -62.16M | |||
All data in USD